Ideal Cures Profile
Key Indicators
- Authorised Capital ₹ 10.10 Cr
as on 23-10-2024
- Paid Up Capital ₹ 7.50 Cr
as on 23-10-2024
- Company Age 36 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.25 Cr
as on 23-10-2024
- Revenue 9.76%
(FY 2023)
- Profit 120.96%
(FY 2023)
- Ebitda 125.87%
(FY 2023)
- Net Worth 26.73%
(FY 2023)
- Total Assets 9.63%
(FY 2023)
About Ideal Cures
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.10 Cr and a paid-up capital of Rs 7.50 Cr.
The company has closed loans amounting to ₹6.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ideal Cures Private Limited India is Dinesh Pandey as COMPANY SECRETARY. Simon Tasker, Sanjay Negi, Dinesh Pandey, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH1988PTC048150
- Company No.
048150
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 1988
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ideal Cures Private Limited offer?
Ideal Cures Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, Company Law & Labour Law Consultants, Statutory Compliance Services, Pharmaceutical Medicine, Online Brand Building Services, Branding Design Services, Calcium Tablet, Calcium Carbonate Tablet, Acrylic Polymers.
Who are the key members and board of directors at Ideal Cures?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maulek Desai  | Managing Director | 12-Apr-2024 | Current |
| Dinesh Pandey | Company Secretary | 01-Nov-2016 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Simon Tasker  | Director | 13-Oct-2021 | Current |
| Sanjay Negi | Director | 12-Dec-2022 | Current |
| Dinesh Pandey | Director and Company Secretary | 12-Dec-2022 | Current |
David Bain  | Additional Director | 10-Jan-2024 | Current |
Financial Performance of Ideal Cures.
Ideal Cures Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.76% increase. The company also saw a substantial improvement in profitability, with a 120.96% increase in profit. The company's net worth Soared by an impressive increase of 26.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ideal Cures?
In 2023, Ideal Cures had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jun 2010 | ₹6.25 Cr | Satisfied |
How Many Employees Work at Ideal Cures?
Ideal Cures has a workforce of 241 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ideal Cures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ideal Cures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
